Invivyd, Inc. (IVVD) Dividend History

Company News

• Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights

  Invivyd reported strong Q4 2024 revenue growth for its COVID-19 antibody PEMGARDA, and positive Phase 1 data for its next-generation candidate VYD2311. The company aims to achieve near-term profitability and continues to advance its pipeline.

  GlobeNewswire Inc.
• Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session

  U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Friday. Shares of Kura Sushi USA, Inc. (NASDAQ: KRUS) climbed 6% to $110.11 in pre-market trading following the release of second-quarter results. The company reported quarterly losses of 9 cents per share, missing the analyst estimate of losses of 3 cents per share. Quarterly sales came in at $57.29 million, beating the $56.64 million analyst consensus estimate, according to data from Benzinga Pro. Kura Sushi shares climbed 6% to $110.11 in pre-market trading. Here ...

  Benzinga

  Featured Companies: CNK CRBU DNUT FAAS FRGE KRUS VTYX
• All You Need to Know About Invivyd, Inc. (IVVD) Rating Upgrade to Strong Buy

  Invivyd, Inc. (IVVD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  Zacks Investment Research
• Invivyd Stock More Than Doubled Last Week. Is It Too Late to Buy?

  The clinical-stage biotech delivered positive trial results for its new COVID-19 preventative antibody treatment.

  The Motley Fool

  Featured Companies: PFE